SALUD MENTAL is a distinguished academic journal published by the Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico, focusing on the ever-evolving fields of Clinical Psychology and Psychiatry and Mental Health. With an ISSN of 0185-3325 and a history of publication dating back to 1995, this journal serves as a pivotal platform for the dissemination of research, innovative practices, and advancements in mental health care. Despite its classification within Q3 quartiles in 2023 for both Clinical Psychology and Psychiatry and Mental Health, SALUD MENTAL continues to strive for excellence, fostering interdisciplinary dialogue and contributions that enrich the understanding of mental health phenomena. Researchers, professionals, and students will benefit from its insightful articles and studies, which address pressing issues in the field, making it an essential resource for those dedicated to improving psychological and psychiatric practices in Mexico and beyond.

Psychology Research and Behavior Management is a leading peer-reviewed journal that serves as a vital resource in the field of psychology and mental health. Published by DOVE MEDICAL PRESS LTD since 2008, this open access journal allows for the free dissemination of knowledge, ensuring that valuable research findings are accessible to a global audience. With an impact factor that positions it within the Q2 category in both Psychiatry and Mental Health as well as in Psychology (miscellaneous), the journal is recognized for its significant contribution to the understanding of behavioral management and psychological health. Its rankings—#61 out of 216 in General Psychology and #222 out of 567 in Psychiatry and Mental Health—further highlight its influence within these critical fields. By providing an avenue for innovative research and insights, Psychology Research and Behavior Management aims to support researchers, professionals, and students in exploring and addressing complex psychological issues, ultimately fostering informed practices and advancements in mental health care.

Addicta - The Turkish Journal on Addictions, published by the esteemed Turkish Green Crescent Society, is an open access journal dedicated to advancing the understanding of addictions and their implications on mental health. Since its inception in 2019, this journal has become a significant platform for interdisciplinary research, focusing on the biological, psychological, and sociocultural aspects of addiction. With a focus on both empirical studies and theoretical discussions, Addicta seeks to foster a greater understanding of addiction as a complex phenomenon, facilitating knowledge sharing among researchers, practitioners, and policymakers. The journal has achieved notable rankings, residing in the Q4 category in Biological Psychiatry and Psychiatry and Mental Health, and Q3 in miscellaneous Psychology, marking its growing impact in the field. Accessing its content is completely free, making important research accessible to a broader audience. Based in Turkey, Addicta provides a vital resource for those interested in the nuances of addiction research, promoting innovative solutions and fostering collaboration across disciplines.

Ansiedad y Estres-Anxiety and Stress is a peer-reviewed journal dedicated to advancing the field of applied psychology, psychiatry, and mental health. Published by the esteemed SOC ESPANOLA ESTUDIO ANSIEDAD & ESTRES, this journal serves as a critical platform for sharing research findings, empirical studies, and theoretical contributions focused on anxiety and stress-related issues. With an ISSN of 1134-7937 and E-ISSN of 2174-0437, the journal has been evolving since 2009 and is published from Madrid, Spain. Ansiedad y Estres has garnered attention within the academic community, with Scopus rankings reflecting its niche yet impactful contributions—ranking in Q3 for Applied Psychology and Q4 for both Psychiatry and Mental Health, and Social Psychology (as of 2023). This journal is committed to fostering interdisciplinary dialogue and encouraging innovative approaches in the understanding and treatment of anxiety and stress disorders. By providing open access to vital research, it aims to benefit not only researchers and professionals but also students who are eager to deepen their knowledge in this essential area of psychology.

EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, published by the American Psychological Association, stands as a pivotal resource within the fields of pharmacology and psychiatry. With an ISSN of 1064-1297 and an E-ISSN of 1936-2293, this journal contributes significantly to the understanding of psychopharmacological interventions through its rich array of research articles, reviews, and clinical studies. Classified within the Q2 category in both Pharmacology and Psychiatry and Mental Health, it reflects a solid standing in academic performance, evidenced by its rankings in Scopus, where it places within the top half of its categories. Spanning from 1993 to 2024, it seeks to provide an essential platform for the dissemination of knowledge and advancements that influence clinical practice and therapeutic approaches. Although not an open-access journal, its impact on the development of evidence-based psychopharmacological treatments cannot be overstated, making it a vital resource for researchers, clinically active professionals, and students eager to stay abreast of cutting-edge developments in mental health and pharmacology.

Terapia Psicologica is a distinguished peer-reviewed journal published by the SOCIEDAD CHILENA PSICOLOGIA CLINICA, focusing on the critical fields of Clinical Psychology and Psychiatry and Mental Health. Since its inception in 2008, this journal has emerged as a pivotal platform for disseminating innovative research and clinical practices in mental health, garnering attention in the academic community with its position in the Q3 quartile as of 2023. The journal serves as an invaluable resource for researchers, professionals, and students seeking to advance their understanding of psychological therapies and mental health interventions. Although Terapia Psicologica does not currently provide open access, its comprehensive scope ensures that vital findings reach a broad audience, enhancing the quality and impact of psychological practice across Chile and beyond. With its ISSN 0718-4808, the journal continues to contribute significantly to the evolving discourse in psychology, maintaining its relevance and importance in shaping future research and therapeutic practices.

Adolescent Psychiatry, an esteemed publication by Bentham Science Publishers, focuses on the intricate and evolving field of adolescent mental health, covering a broad spectrum of topics relevant to both psychiatry and pediatrics. With its ISSN of 2210-6766 and E-ISSN of 2210-6774, this journal contributes significantly to its fields through rigorous research articles, clinical studies, and comprehensive reviews that enhance our understanding of adolescent psychological well-being. Operating out of the United Arab Emirates, this journal's impact is reflected in its Scopus rankings, placing it within the Q3 category of Pediatrics and Q4 in Psychiatry and Mental Health for 2023. Although not an open-access journal, it remains a vital resource for researchers, clinicians, and students seeking to advance their knowledge and practice regarding mental health issues in adolescents. With converged publication years from 2014 to 2015 and from 2019 to 2024, it continues to strive for excellence in publishing high-quality research that tackles contemporary challenges in adolescent psychiatry.

JOURNAL OF PSYCHOACTIVE DRUGS, published by Routledge Journals, Taylor & Francis Ltd, stands as a leading resource in the fields of psychology and medicine, focusing on the intersection of psychoactive substances and their impact on human behavior. With an ISSN of 0279-1072 and E-ISSN 2159-9777, this esteemed journal has been a pivotal platform for rigorous research since its inception in 1967, contributing to the understanding of drug use, its societal implications, and therapeutic potentials. It currently holds a Q2 ranking in both the miscellaneous categories of Medicine and Psychology for 2023, reflecting its significant standing within academic circles. Moreover, its Scopus rankings place it at the 49th percentile in General Psychology and 101st in Medicine, underscoring its relevance in contemporary research. Although it is not available via Open Access, the journal maintains a commitment to advancing knowledge through its annual publications until 2024. JOURNAL OF PSYCHOACTIVE DRUGS is essential for researchers, professionals, and students seeking to explore the complexities of psychoactive substances and their effects in various contexts.

The Journal of Homosexuality, published by Routledge Journals, Taylor & Francis Ltd, stands as a pivotal peer-reviewed platform dedicated to advancing research in the fields of gender studies, psychology, education, and related disciplines since its inception in 1974. With an impressive range of quartile rankings in Q1 categories such as Education, Gender Studies, and Social Psychology, this journal is recognized for its high impact, as evidenced by its Scopus rank in the 94th percentile of Gender Studies. Researchers and practitioners turn to this journal not only for its rigorous academic standards but also for its commitment to promoting understanding and dialogue concerning LGBTQ+ issues. Although it does not currently offer open access, the journal remains indispensable for scholars seeking to engage with transformative theories and empirical research that challenge the status quo. By fostering an inclusive scholarly community, the Journal of Homosexuality contributes significantly to an enhanced understanding of sexual orientation and its implications in various social contexts.

The Journal of Dual Diagnosis, published by Routledge Journals, Taylor & Francis Ltd, is a leading interdisciplinary platform dedicated to the critical study of co-occurring mental health and substance use disorders. With its ISSN 1550-4263 and E-ISSN 1550-4271, this esteemed journal has been at the forefront of advancing research and clinical practice since its inception in 2004, and continues to serve as a vital resource until 2024. Ranked in the second quartile (Q2) in Psychiatry and Mental Health and positioned at the 64th percentile in the Scopus rankings, it emphasizes the importance of integrating care across various domains of health. Although not open access, it offers a wealth of peer-reviewed articles, case studies, and reviews suitable for researchers, practitioners, and students alike, aiming to enhance our understanding and treatment of dual diagnosis. The journal's commitment to addressing the complexities of dual disorders not only informs research but also shapes policy and clinical guidelines, making it an essential read for anyone involved in these critical areas of mental health.